EP
BIIB icon

Essential Partners’s Biogen BIIB Stock Holding History

Essential Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$306K Hold
1,355
– – 0.14% 157
2026
Q2 		$293K Sell
1,355
-4,364
-76% -$835K 0.13% 165
2026
Q1 		$1.05M Buy
5,719
+5
+0.1% +$921 0.35% 67
2025
Q4 		$1.01M Buy
5,714
+155
+3% +$25.3K 0.31% 87
2025
Q3 		$779K Buy
5,559
+214
+4% +$28.9K 0.26% 104
2025
Q2 		$671K Buy
+5,345
New +$666K 0.27% 114

Other funds holding BIIB

Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Beau Ventures, LLc
Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return
Banque Pictet & Cie
Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return
Gateway Investment Advisers
Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return
CIM
Contravisory Investment Management Norwell, Massachusetts $552M AUM 32.44% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Generali Investments CEE
Generali Investments CEE Prague, Czech Republic $2.11B AUM 18.35% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Essential Partners's BIIB Position: Q3 2026 in Review

Essential Partners held its Biogen (BIIB) position steady in Q3 2026 at 1,355 shares worth $306K. The position accounts for 0.14% of the portfolio, ranked #157.

Essential Partners first reported a position in BIIB in Q2 2025 and has held it in 6 quarters since. The position peaked at $1.05M in Q1 2026. 133 funds tracked by Wall St. Rank hold BIIB as of Q3 2026.

  • Essential Partners held 1,355 shares of Biogen worth $306K as of Q3 2026.
  • Essential Partners left its Biogen share count unchanged in Q3 2026.
  • Biogen made up 0.14% of Essential Partners's portfolio in Q3 2026, its #157 holding.
  • Essential Partners first reported a position in Biogen in Q2 2025 and has held it in 6 quarters since.
  • Essential Partners's Biogen position peaked at $1.05M in Q1 2026.
  • 133 funds tracked by Wall St. Rank held Biogen as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.